As of March 2026 Catalyst Pharmaceuticals has a market cap of NZ$4.79 Billion. This makes Catalyst Pharmaceuticals the world's 4024th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 21st, 2026 the market cap of Catalyst Pharmaceuticals was reported to be: